ORIGINAL RESEARCH article
Front. Immunol.
Sec. Viral Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1700988
Methionine enkephalin upregulates Toll-like receptors in macrophages to suppress severe fever with thrombocytopenia syndrome virus infection
Provisionally accepted
- 1Jinzhou Medical University, Jinzhou, China
- 2Shenyang Medical College, Shenyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly identified tick-borne virus with a high case fatality rate. Currently, no specific antiviral drugs are available for its treatment. Methionine enkephalin (MENK) has the ability to enhance immune cell function nonspecifically. This study investigated the mechanism by which MENK regulates macrophages to exert antiviral effects against SFTSV infection. Methods: An SFTSV-infected RAW264.7 macrophage model pretreated with MENK was developed. RNA sequencing was employed to analyze transcriptomic alterations and identify differentially expressed genes (DEGs). Subsequent experimental validation based on bioinformatics analysis was performed on key DEGs. Results: The DEGs between the MENK–SFTSV and SFTSV groups were mainly enriched in several signaling pathways, including the Toll-like receptor (TLR) signaling pathway (ko04620), IL-17 signaling pathway (ko04657), TNF signaling pathway (ko04668), and interaction between viral proteins and cytokines and their receptors (ko04061). Key genes included TLR7, TLR3, TLR8, TLR9, activator protein-1 (AP-1), IL-17RA, TNF-α, IL-1β, CCR5, and CXCL10, all of which successfully docked with the MENK molecule. Compared with the TLR7 agonist imiquimod (IMQ), MENK demonstrated a greater advantage in modulating macrophages to resist SFTSV infection. MENK and the TLR7 agonist imiquimod can upregulate the expressions of TLR7, TLR3, AP-1, and IL-17RA. In addition, MENK significantly upregulated the levels of TLR9, TLR8, IL-1β, TNF-α, CCR5, and CXCL10. Conclusion: MENK upregulated the expression levels of the pattern recognition receptors and cytokine receptors; promoted the nuclear transcription to modulate cellular immune responses; and increased the levels of the cytokines to induce inflammatory responses against SFTSV infection. Notably, MENK possessed unique advantages and exhibited efficacy comparable to IMQ in restoring antiviral immunity, suggested that MENK emerged as a promising host-directed therapeutic candidate or vaccine prototype against SFTSV infection, warranting further preclinical and clinical investigation.
Keywords: Methionine Enkephalin, Toll-Like Receptors, Macrophages, Severe Fever with Thrombocytopenia Syndrome Virus, RNA sequencing
Received: 08 Sep 2025; Accepted: 21 Oct 2025.
Copyright: © 2025 Tian, Ping Ma, Wang, Li and Tao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jing Tian, 229157364@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.